F1PART 2Capital Fees for Pre-Application Meetings
Annotations:
Amendments (Textual)
Interpretation of Part 2F13
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Fee for scientific advice: application for, or variation to, EU marketing authorisationF14
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Fee for scientific advice: classification of a medicinal productF15
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Fee for advertising adviceF16
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Fee for pharmacovigilance adviceF17
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Fee for advice on labelling or leafletsF18
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Fee for regulatory adviceF19
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Fee for advice for other purposesF110
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Time for payment of fees under regulations 4 to 10F111
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Regulations revoked (1.4.2016) by The Medicines (Products for Human Use) (Fees) Regulations 2016 (S.I. 2016/190), reg. 63(1) (with reg. 63(2)-(4))